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Abstract
Introduction: Acromegaly is a rare, chronic, disfiguring, and debilitating disease caused, in 90% of
cases, by a benign monoclonal growth hormone–secreting pituitary adenoma. The present study
aimed to assess left ventricular (LV) rotational and twist mechanics in acromegalic patients and to
compare their results to age- and gender-matched healthy controls.
Methods: The present study comprised 24 acromegalic patients, from which 4 were excluded due
to insufficient image quality (mean age: 57.8613.7 years, 7 men). The control group consisted of
18 age- and gender-matched healthy individuals (mean age: 54.866.9 years, 8 men).
Results: In 4 out of 20 acromegalic patients, LV showed near absence of twist, as the so-called LV
“rigid body rotation” (RBR). Between all acromegalic patients without LV-RBR and controls, both
LV basal (–3.7661.73 vs. 26.1762.668, P5 .004) and apical rotation (6.1264.03 vs. 10.816
3.658, P5 .001) and LV twist (9.8864.74 vs. 16.9863.888, P< .001) differed significantly.
Between active and nonactive acromegaly subgroups, only the time-to-peak LV twist (377678
vs. 229697 ms, P5 .005) showed significant difference.
Conclusions: Acromegaly is associated with impaired LV rotation and twist as assessed
by 3-dimensional speckle tracking echocardiography. LV-RBR is a frequent phenomenon in
acromegaly.
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1 | INTRODUCTION
Acromegaly is a rare, chronic, disfiguring, and debilitating disease
caused, in 90% of the cases, by a benign monoclonal growth hormone
(GH)-secreting pituitary adenoma.1 The excessive amount of GH and
consequently elevated levels of insulin-like growth factor-1 (IGF-1)
entail a wide range of clinical symptoms and coexisting illnesses, includ-
ing cardiovascular, endocrine, respiratory, and metabolic morbidities.2,3
Cardiovascular involvement can be seen in 60% of acromegalics and
entails hypertension, concentric left ventricular (LV) hypertrophy, heart
failure, and aortic and mitral valve regurgitation. In rare cases, arrhyth-
mias and sudden death may occur. The severity of these cardiac com-
plications is directly related to the overall duration of elevated GH
secretion rather than to the GH or IGF-1 levels themselves.4,5
In healthy subjects, the complex contraction of 2 orthogonally ori-
ented muscular bands of the LV helical myocardium structure is
responsible for the LV apex counterclockwise rotation while simultane-
ously causing the basis to rotate in a clockwise direction.6–8 This
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complex myocardial motion is called LV rotation, and it contributes
greatly to the normal function of the LV. The net difference between
LV basal and apical rotations is called LV twist.9 In some special circum-
stances, the near absence of LV twist could be demonstrated when LV
apex and base rotate in the same direction. This sort of movement is
called LV “rigid body rotation” (RBR).10,11 Three-dimensional (3D)
speckle tracking echocardiography (3DSTE) is a relatively new, robust,
and noninvasive tool that offers a possibility not only to visualize but
also to measure LV rotation and twist.12 The present study aimed to
assess LV rotational and twist mechanics in acromegalic patients and to
compare their results to age- and gender-matched healthy controls. To
the best of the authors’ knowledge, LV rotation and twist characteris-
tics have never been examined before in a series of patients with
acromegaly.
2 | PATIENTS AND METHODS
2.1 | Patient population
The present study comprised 24 acromegalic patients, from which 4
were excluded due to insufficient image quality (mean age: 57.8613.7
years, 7 men). Acromegaly was diagnosed based on typical clinical fea-
tures and elevated serum human growth hormone (hGH) and IGF-1
levels not suppressible with oral glucose tolerance test (OGTT, 75 g).5
Acromegaly was considered active if serum hGH levels and/or serum
IGF-1 levels were above the diagnostic threshold.5,13 IGF-1 indices
were also calculated in acromegalic patients, where serum IGF-1 con-
centration was divided by the upper limit of normal serum IGF-1 level
of the same age and sex control group. All patients were referred from
the Endocrinology Unit, 1st Department of Medicine at the University
of Szeged. As a tertiary center, this unit is responsible for the treatment
of all acromegalic patients in the region of South-East Hungary. The
patient population was further divided into subgroups based on the
activity of the disease. However, because of their special LV rotational
mechanics, clinical and echocardiographic data of acromegalic patients
with LV-RBR were managed and discussed separately.
Mean level of serum hGH was 5.5066.75 ng/mL; mean IGF-1
serum level was 332.46204.0 ng/mL, and mean IGF-1 index was
1.4560.91 across all acromegalic patients. Active acromegaly sub-
group consisted of patients before hypophysectomy, patients who
underwent surgery but had hormonally active remnant tissue, or
treated patients who had elevated IGF-1 levels despite long-acting
somatostatin analogue therapy (n512). Mean hGH level in this group
was 4.7964.06 ng/mL; mean IGF-1 serum level was 3986217 ng/
mL, and mean IGF-1 index was 1.7960.89. Inactive acromegaly sub-
group included patients who had normal serum IGF-1 and/or normal
serum hGH levels or normal hGH nadir levels after OGTT during long-
acting somatostatin analogue, bromocriptine, or pegvisomant therapy,
or patients who underwent successful hypophysectomy (n58). Mean
hGH level in this group was 1.6761.68 ng/mL; mean IGF-1 serum
level was 1816113 ng/mL; mean serum levels of nadir hGH after
OGTT was 1.9862.28 ng/mL; and mean IGF-1 index was 0.7660.49
ng/mL. None of the acromegalic patients had history of chest pain or
myocardial infarction, but coronary angiography was not performed to
rule out coronary artery disease.
The control group consisted of 18 age- and gender-matched
healthy individuals (mean age: 54.866.9 years, 8 men). Both the acro-
megaly and the control group successfully underwent transthoracic 2-
dimensional (2D) Doppler echocardiography and 3DSTE. The institu-
tion’s human research committee approved the study, which also com-
plied with the ethical guidelines set by the 1975 Declaration of
Helsinki. All patients gave informed consent. The present study was a
part of the MAGYAR-Path Study (Motion Analysis of the heart and
Great vessels bY three-dimension Al speckle-tRacking echocardiogra-
phy in Pathological cases), which aimed to examine pathophysiological
consequences of different pathological states on myocardial mechanics
among others (“magyar” means “Hungarian” in the Hungarian language).
Control subjects were randomly selected from the MAGYAR-Healthy
Study. Hundreds of healthy control subjects were involved on a volun-
tary basis in this study at our center to validate 3DSTE-derived param-
eters, to examine their clinical, diagnostic, and prognostic value, and to
compare them to other known echocardiographic parameters.
2.2 | 2D echocardiography
Transthoracic 2D imaging and measurements were carried out by experi-
enced operators (P.D., A.K.) using a Toshiba Artida imaging system (Toshiba
Medical Systems, Tokyo, Japan) and a PST-30SBP (1–5 MHz) phased-array
transducer. In all cases, complete 2D Doppler study was performed fol-
lowed by the measurement of LV dimensions, volumes and ejection frac-
tion, and left atrial (LA) dimensions according to current clinical standards.14
Visual assessment was used for the evaluation of valve regurgitations.
2.3 | 3DSTE measurements
3DSTE measurements were carried out using the same echocardiogra-
phy system with PST-25SX matrix-array transducer (Toshiba Medical
Systems). To obtain full-volume 3D datasets, 6 wedge-shaped subvo-
lumes, acquired during a single breath-hold and constant RR interval
from the apical window, were combined. For better spatial resolution,
thus improved border delineation, sector width was chosen to be as nar-
row as possible. Offline image analysis was performed using 3D Wall
Motion Tracking software version 2.7 (Toshiba Medical Systems). From
the pyramidal 3D echocardiography datasets, the software automatically
selected the apical 2-chamber and 4-chamber views and 3 short-axis
views at end-diastole. To standardize the 3 short-axis views across all
measurements, we used the additional guide planes provided by the
software: at end-diastole, the bottom and the top guide planes were
placed just above the mitral plane and the very apex of the heart, respec-
tively. This way, all 3 short-axis views fell to the same part of the LV in
every case. Measurements were made during a complete heart cycle.
LV rotational and twist parameters:
 LV basal (defined as the degree of clockwise rotation of LV basal
myocardial segments) and apical rotation (defined as the degree of
counterclockwise rotation of LV apical myocardial segments).
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 LV twist (defined as the net difference between LV basal and apical
rotation).
LV time-to-peak rotational parameters:
 Time to peak degree of LV basal and apical rotation from the start of
the heart cycle.
 Time to peak degree of LW twist from the start of the heart cycle.
In the case of LV-RBR–like movement, proper LV twist data could not
be gathered due to the very different pattern of LV basal and apical
rotation (Figure 2); therefore, apico-basal gradient was calculated as
end-systolic LV apical minus LV basal rotation.
2.4 | Statistical analysis
All data are reported as mean6 standard deviation. P values <.05 were
considered significant. Fisher’s exact test was used for categorical vari-
ables. Shapiro-Wilks test was used to test normal distribution in every
dataset. Homogeneity of variance was assessed using Levene’s Test for
Equality of Variances. Student’s t test was used for datasets following
normal distribution and Mann-Whitney-Wilcoxon test was used for
datasets that were not normally distributed. RStudio was used for
statistical analysis (RStudio Team, Integrated Development for R. RStu-
dio, Inc, Boston, Massachusetts). For offline data analysis and graph
creation, we used MATLAB 8.6 (The MathWorks Inc, Natick,
Massachusetts).
3 | RESULTS
3.1 | Demographic data of acromegalic patients
In 4 acromegalic patients, 3DSTE showed signs of LV-RBR–like move-
ment, and their data were analyzed separately from those of the other
patients. Between the control population and the remaining 16 acro-
megalic patients without LV-RBR–like movement, there were signifi-
cantly more patients with hypertension (P< .001), diabetes mellitus
(P5 .04), and hypercholesterolemia (P5 .002). We got the same results
between active acromegaly patients and controls (P< .001, P5 .01,
P5 .01, respectively). Between inactive acromegaly patients and the
healthy control population, only the number of patients with hyperten-
sion (P50.001) and hypercholesterolemia (P5 .01) was significantly
different. There were no significant differences between the active and
inactive acromegaly subgroups regarding demographic data (Table 1).
FIGURE 1 A, Apical 4-chamber, and B, 2-chamber views and short-axis views, C3, C5, C7, at different levels of the left ventricle (LV)
extracted from the 3-dimensional (3D) echocardiographic dataset in a patient with active acromegaly. D, The 3D mesh model of the left
ventricle, and E, calculated LV volumetric data are also presented
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Data regarding the treatment of acromegaly and the number of
patients who underwent hypophysectomy are also shown in Table 1.
3.2 | 2D echocardiographic data
We found significant differences in LA diameter (P5 .003), LV end-
diastolic diameter (P5 .001), LV-end-diastolic volume (P< .001), and early
filling transmitral flow velocity (E) (P5 .03) between all acromegalic
patients without LV-RBR and controls. Between controls and active and
inactive acromegaly patients without LV-RBR subgroups, LA diameter
(P5 .02 and P5 .02, respectively), LV-end-diastolic diameter (P< .001
and P5 .04, respectively) and LV-end-diastolic volume (P< .001 and
P5 .01, respectively) differed significantly. No significant differences could
be demonstrated between active and inactive subgroups regarding 2D
echocardiographic variables (Table 1). None of the subjects examined
showed grade 3 to 4 mitral or tricuspid regurgitation.
3.3 | 3DSTE-derived LV rotation and twist
Between all acromegalic patients without LV-RBR–like movement and
controls, both LV basal and apical rotation and LV twist differed signifi-
cantly (P5 .0037, .0012, <.001, respectively). Between active and inac-
tive acromegaly subgroups, only the time-to-peak LV twist showed
significant difference (P5 .005). Between active acromegalics without
LV-RBR–like movement and controls, LV basal (P5 .003) and apical
rotations (P5 .02) and LV twist (P5 .003) differed significantly.
Between inactive acromegaly patients without LV-RBR–like movement
and controls, LV apical rotation (P5 .001), LV twist (P5 .002), and
time-to-peak LV twist (P5 .04) differed significantly (Table 2).
3.4 | Acromegaly patients with LV-RBR-like
movement
As mentioned before, 4 out of 20 acromegalic patients showed LV-
RBR–like movements demonstrating apical and basal LV rotations in
the same direction. Demographic and 2D echocardiographic data of
these patients are shown in Table 1. Among these 4 patients, 2 were
active acromegaly patients, and 3 had had hypophysectomy. There
were no significant differences between acromegalic patients with LV-
RBR–like movement and other patient subgroups as for demographic
and 2D echocardiography parameters.
Three out of 4 patients had counterclockwise LV rotation with LV
basal and apical rotations and mean apicobasal LV gradient of
25.81862.998, 20.88861.708, and 5.05862.068, respectively. Only
one acromegaly patient showed clockwise LV-RBR with the same val-
ues of 1.398, 4.068, and 2.678. LV apical rotation and LV twist differed
significantly between patients with counterclockwise LV-RBR–like
movement and controls (P< .001 and P5 .002, respectively). Between
acromegalic patients with counterclockwise LV-RBR–like movement
FIGURE 2 Mean basal, midventricular, and apical LV rotations across various groups are shown. Abbreviations: APICAL, mean LV apical
rotation (blue curve); BASAL, mean LV basal rotation (red curve); MID, mean LV midventricular rotation (green curve)
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and acromegalic patients without LV-RBR–like movement, only LV api-
cal rotation (P5 .01) was significantly different (Table 2).
4 | DISCUSSION
Acromegaly is a chronic, endocrine disorder with major cardiovascular
comorbidity. Most prominent is hypertension, which occurs in almost
90% of acromegaly cases. The underlying pathophysiology is not clearly
understood. Elevated serum GH levels and consequent plasma volume
expansion, increased peripheral vascular resistance, and the hormone’s
antinatriuretic effect may be involved. Systemic hypertension is not
related to age or gender in acromegaly.15 Increased peripheral circulatory
resistance and hypertension entail increased cardiac workload.15–17 Fur-
thermore, acromegaly causes a specific type of cardiomyopathy, in which
















Age (years, mean6 SD) 54.866.9 50.06 10.6 59.76 13.9 62.3612.0 55.3616.8
Male gender, n (%) 8 (40) 1 (25) 6 (38) 4 (40) 2 (33)
Hypertension, n (%) 0 (0) 1 (25) 11 (69)a 7 (70)b 4 (67)c
Diabetes mellitus, n (%) 0 (0) 0 (0) 4 (25)a 4 (40)b 0 (0)
Hyperlipidaemia, n (%) 0 (0) 2 (50) 7 (44)a 4 (40)b 3 (50)c
Active acromegaly, n (%) 0 (0) 2 (50) 10 (63) 10 (100) 0 (0)
Treatment
Somatostatin analogue, n (%) 0 (0) 1 (25) 6 (38) 5 (50) 1 (17)
Bromocriptine, n (%) 0 (0) 0 (0) 7 (44) 4 (40) 3 (50)
Pegvisomant, n (%) 0 (0) 0 (0) 1 (6) 1 (10) 0 (0)
Hypophysectomy, n (%) 0 (0) 3 (75) 2 (13) 2 (20) 0 (0)
Two-dimensional echocardiography
LA diameter (mm) 37.065.7 37.56 4.3 43.26 5.3a 42.865.1b 43.765.9c
LV end-diastolic diameter (mm) 46.763.8 48.76 6.9 52.46 5.4a 52.964.5b 51.566.9c
LV end-diastolic volume (mL) 102.16 19.3 113.56 38.2 135.7628.4a 137.5624.8b 132.6635.9c
LV end-systolic diameter (mm) 30.462.8 30.76 3.2 32.56 5.2 31.765.3 33.865.3
LV end-systolic volume (mL) 36.067.0 37.66 9.2 44.46 16.5 41.8615.8 48.6618.1
Interventricular septum (mm) 10.061.9 9.46 1.7 10.66 1.8 11.061.9 10.061.4
LV posterior wall (mm) 10.361.9 10.26 1.8 11.26 1.9 11.561.5 10.662.6
LV ejection fraction (%) 64.464.1 66.26 3.3 67.26 8.5 69.1610.0 64.164.1
E (cm/s, mean6 SD) 72.5615.8 65.86 11.3 61.6 610.0a 62.169.4 60.8611.9
A (cm/s, mean6 SD) 75.9617.4 86.16 7.3 76.26 17.2 78.7618.8 71.9614.8
E/A (mean6 SD) 1.0060.32 0.766 0.11 0.846 0.22 0.8260.19 0.8860.28
Abbreviations: LA, left atrial; LV, left ventricular; LV-RBR, left ventricle “rigid-body rotation”; SD, standard deviation.
aP< .05 between acromegaly without LV-RBR group and controls.
bP< .05 between active acromegaly group without LV-RBR and controls.
cP< .05 between nonactive acromegaly group without LV-RBR and controls.












LV basal rotation (8) 26.1762.66 23.7661.73a 23.746 1.19b 23.806 2.52
LV apical rotation (8) 10.816 3.65 6.126 4.03a 7.2863.77b 4.1864.00c
LV twist (8) 16.986 3.88 9.886 4.74a 11.0364.04b 7.9865.58c
Time-to-peak LV basal rotation (ms) 356699 3466 144 3566 98 3296210
Time-to-peak LV apical rotation (ms) 356679 3176 98 3426 75 2776125
Time-to-peak LV twist (ms) 337664 3216 110 3776 78d 229697c
Abbreviations: LV, left ventricular; RBR, rigid body rotation.
aP< .05 between acromegaly without LV-RBR group and controls.
bP< .05 between active acromegaly without LV-RBR group and controls.
cP< .05 between inactive acromegaly without LV-RBR group and controls.
dP< .05 between active acromegaly without LV-RBR group and inactive acromegaly without LV-RBR group.
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hypertrophy occurs early in the disease, and prolonged elevated serum
GH levels may increase prevalence up to 70%-90% of all acromegaly
cases. In the early stages, increased Ca21 sensitivity and myocardial con-
tractibility dominate, causing hyperkinetic syndrome and concentric LV
hypertrophy. As the cardiac involvement progresses, the myocardial
hypertrophy becomes more pronounced, diastolic LV filling decreases,
and preejection time is prolonged. In the later stages, cardiac extracellu-
lar collagen deposition, diastolic and systolic dysfunction due to cardiac
remodeling, and heart failure become prominent. Later stages can be
observed in older patients, in untreated acromegaly, or in cases of pro-
longed elevated serum GH levels.18–21 Valvular regurgitations are also
frequent, the mitral valve being affected in most cases.22 Specific
arrhythmias might also develop, mostly paroxysmal atrial fibrillation.23
Last, we previously demonstrated that acromegaly is associated with
increased aortic stiffness.24 These changes are probably due to extracel-
lular collagen deposition and consequent remodeling of the cardiac
muscle. However, to the best of our knowledge, this is the first study
to examine LV rotational patterns and mechanics in patients with
acromegaly.
In the present study, 3DSTE was used for the quantification of LV
basal and apical rotations and LV twist, which is considered to be the
net difference of the clockwise LV basal rotation and the counterclock-
wise LV apical rotation. The conventional indices of LV function have
no capability to characterize LV rotational mechanics. For instance,
myocardial performance index is a combined systolic-diastolic parame-
ter featuring global LV performance, whereas the E/A ratio represents
LV diastolic function. Because of recent developments in echocardiog-
raphy, there is now the opportunity to quantify LV rotational mechan-
ics, which have a significant role in ejection. To date, the number of
clinical studies concerning the echocardiographic measurement of LV
rotation and twist is limited, although 3DSTE has been validated for
the analysis of LV rotational mechanics. During 3DSTE examination, a
complete 3D dataset is acquired, which is a major advantage over 2D
speckle tracking, as the 3D motion of speckles can easily be detected
throughout the cardiac cycle, and rotational parameters at each level of
the LV can be estimated from the same dataset at the same time. How-
ever, as the frame rate is limited with this methodology, only individu-
als with good acoustic window can undergo 3DSTE, because the
software requires visible LV walls for tracking during the whole cardiac
cycle.25,26 It is worth noting, though, that 3DSTE has a tendency to
underestimate the degree of LV rotation and twist compared with
2DSTE.27 The advantages of 3DSTE far outweigh its disadvantages: it
is fast, reproducible, and measurements do not require specific skill.
In our patients, 2D echocardiography showed an enlarged heart
with impaired early filling transmitral flow velocity, and the E/A ratio
appeared lower but not significantly different from that of healthy con-
trols. 3DSTE-derived LV basal and apical rotation and LV twist also
underlined this pattern: both LV apical and basal rotation and twist
proved to be diminished in acromegalic patients; furthermore, LV-
RBR–like characteristics could be demonstrated in 4 cases. The impair-
ment of diastolic filling, and the high ratio (20%) of cases showing RBR-
like motion of the LV and diminished LV basal and apical rotation and
LV twist, could be signs of acromegaly-related cardiomyopathy.28 Our
findings are concordant with the above described clinical and patho-
physiological features regarding the special cardiomyopathy associated
with acromegaly.
The present study was affected by several limiting factors. The
most important was the relatively small number of patients involved,
although acromegaly is a relatively rare disorder. We did not examine
the effects of the drugs used with acromegaly patients. We did not
take into account the elapsed time after the diagnosis and treatment
and for how long the elevated serum GH levels may have been present.
Our study was aimed to examine only LV rotational parameters,
although 3DSTE also allows simultaneous assessment of LV volumetric
data and strain parameters. Moreover, calculation of volumetric and
functional features of left and right atrium is also possible by this meth-
odology. 3DSTE itself suffers from several technical limitations, the
most important being its inferior spatial and temporal resolution com-
pared with standard 2D echocardiography. For proper speckle tracking,
only images where the entire LV wall is visible thorough the cardiac
cycle can be used. Also, because the full 3D volume datasets are
obtained through 6 RR intervals, there may be a “stitching noise”
between individual subvolumes.29 Previously, a comparison study
revealed that the deformation data showed some level of vendor-
dependency.30
In summary, acromegaly is associated with impaired LV rotation
and twist as assessed by 3DSTE. LV-RBR is a frequent phenomenon in
acromegaly.
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